Table 2.
Study area | Overall prevalence (%) | Single Plasmodium spp. response | Multiple Plasmodium spp. response | Single spp. anti-MSP-119 Ab responses | Multiple spp. anti- MSP-119 Ab responses | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Falciparum | Malariae | Ovale | Falciparum/malariae only | Falciparum/ ovale only | Falciparum/ vivax only | Malariae/ ovale only | Falciparum/ malariae and ovale | ||||
Burma valley (n = 100) | 61 | 30 (49.2) | 31 (50.8) | 24 (80) | 3 (10) | 3 (10) | 26 (83.9) | 2 (6.5) | 0 | 1 (3.1) | 2 (6.5) |
Mutoko (n = 100) | 31 | 15 (48.4) | 16 (51.6) | 11 (68.8) | 0 | 4 (31.2) | 6 (37.5) | 2 (12.5) | 0 | 3 (18.8) | 5 (31.2) |
Chiredzi (n = 100) | 32 | 23 (71.9) | 9 (28.1) | 18 (78.3) | 3 (13) | 2 (8.7) | 6 (66.7) | 0 | 1 (11.1) | 0 | 2 (22.2) |
Values indicate the number of responders while those in parenthesis are expressed as % of responders in the respective categories
n number of individuals